Andrew G. Geiser

6.3k citations

47 papers · 5.3k indexed · 1 hit paper · h-index 32

Molecular Biology top 2%
Oncology top 2%
Immunology top 2%
Genetics top 2%
Cancer Research top 5%

Co-authors: Michael B. Sporn Anita B. Roberts Alistair B. Roberts A B Kulkarni Stefan Karlsson Kathleen C. Flanders John J. Letterio Jerrold M. Ward
Topics: TGF-β signaling in diseases (18 papers)Estrogen and related hormone effects (8 papers)Cancer-related gene regulation (7 papers)
Cited by: Immunology and Allergy Oncology Immunology
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Australia Russia

In The Last Decade

Andrew G. Geiser

47 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

1993 1.6k citations Andrew G. Geiser, Alistair B. Roberts et al. profile →

Peers

Countries citing papers authored by Andrew G. Geiser

Since Specialization

Citations

This map shows the geographic impact of Andrew G. Geiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Geiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Geiser more than expected).

Fields of papers citing papers by Andrew G. Geiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew G. Geiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Geiser. The network helps show where Andrew G. Geiser may publish in the future.

Co-authorship network of co-authors of Andrew G. Geiser

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew G. Geiser. A scholar is included among the top collaborators of Andrew G. Geiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew G. Geiser. Andrew G. Geiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective RAR gamma antagonist LY2813631 protects against retinoid induced cartilage degradation in preclinical models of arthritis 2013 ·Osteoarthritis and Cartilage ·Bryan H. Norman,Andrew G. Geiser,M.G. Chambers,T L Moore,S. Chandrasekhar,Todd J. Page,Thomas J. Bleisch,Peter G. Mitchell	1
2	DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids 2007 ·BMC Women s Health ·Tao Wei,Andrew G. Geiser,Hui-Rong Qian,Su Chen,Leah M. Helvering,(unknown),Jianyong Shou,(unknown),Henry U. Bryant,Jude E. Onyia	25
3	Multiple Forms of TGF‐β: Distinct Promoters and Differential Expression 2007 ·Novartis Foundation symposium ·Anita B. Roberts,(unknown),Takafumi Noma,Adam B. Glick,(unknown),Robert J. Lechleider,Sonia B. Jakowlew,Andrew G. Geiser,Michael A. O’Reilly,David Danielpour,Michael B. Sporn	26
4	PINP: A serum biomarker of bone formation in the rat 2006 ·Bone ·Laura V. Hale,Rachelle J. Sells Galvin,Juha Risteli,Yanfei Ma,Anita K. Harvey,Xiaonan Yang,R. L. Cain,Qinghe Zeng,Charles A. Frolik,Masahiko Sato,Allen Schmidt,Andrew G. Geiser	64
5	A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity, Agonist Activity in Bone, and Minimal Ovarian Stimulation 2005 ·Endocrinology ·Andrew G. Geiser,Conrad W. Hummel,Michael W. Draper,Judith Henck,(unknown),Daniel G. Rudmann,(unknown),Mary D. Adrian,Timothy A. Shepherd,Owen B. Wallace,Denis McCann,(unknown),Henry U. Bryant,Masahiko Sato,Jeffrey A. Dodge	42
6	Benzothiophene and naphthalene derived constrained SERMs 2004 ·Bioorganic & Medicinal Chemistry Letters ·Owen B. Wallace,Henry U. Bryant,Pamela K. Shetler,Mary D. Adrian,Andrew G. Geiser	8
7	Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling 2003 ·Molecular Endocrinology ·Venkatesh Krishnan,Terry L. Moore,Yanfei Li,Leah M. Helvering,Charles A. Frolik,(unknown),Patricia Ducy,Andrew G. Geiser	114
8	Bone Anabolic Effects of Sonic/Indian Hedgehog Are Mediated By BMP-2/4-Dependent Pathways in the Neonatal Rat Metatarsal Model 2001 ·Endocrinology ·Venkatesh Krishnan,Yanfei Li,J. M. Moseley,Andrew G. Geiser,Sylvie Friant,Charles A. Frolik	35
9	Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes 2000 ·Gene ·Leah M. Helvering,(unknown),Xuemei Ou,Andrew G. Geiser	83
10	Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice 1997 ·The Journal of Immunology ·Toru Nakabayashi,John J. Letterio,Andrew G. Geiser,Ling‐Yuan Kong,Noriyoshi Ogawa,Weiguo Zhao,T Koike,Gabriel Fernandes,H Dang,Norman Talal	44
11	Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. 1996 ·The Journal of Experimental Medicine ·Yoram Vodovotz,Andrew G. Geiser,Louis Chesler,John J. Letterio,Andrew Campbell,M. Scott Lucia,Michael B. Sporn,Anita B. Roberts	91
12	The Liver in Transforming Growth Factor-Beta-1 (TGF-β1) Null Mutant Mice 1996 ·Ultrastructural Pathology ·A. Olufemi Williams,Alan Knapton,Andrew G. Geiser,John J. Letterio,Anita B. Roberts	25
13	Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor Gene 1995 ·Journal of Biological Chemistry ·Hyun W. Bae,Andrew G. Geiser,David H. Kim,Michelle Chung,James K. Burmester,Michael B. Sporn,Anita B. Roberts,Seong‐Jin Kim	109
14	SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice 1995 ·The Journal of Immunology ·Ha V. Dang,Andrew G. Geiser,John J. Letterio,Toru Nakabayashi,Ling‐Yuan Kong,Gustavo Vicentis Oliveira Fernandes,N Talal	149
15	Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Spl 1993 ·Gene ·Andrew G. Geiser,Klaus J. Busam,Seong‐Jin Kim,Robert Lafyatis,Michael A. O’Reilly,(unknown),Anita B. Roberts,Michael B. Sporn	76
16	Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter. 1992 ·Journal of Biological Chemistry ·Marc O’Reilly,Andrew G. Geiser,(unknown),Leslie A. Bruggeman,Alan Luu,Alistair B. Roberts,Michael B. Sporn	48
17	Characterization of the Mouse Transforming Growth Factor-β1 Promoter and Activation by the Ha-ras Oncogene 1991 ·Molecular and Cellular Biology ·Andrew G. Geiser,Seong‐Jin Kim,Anita B. Roberts,Michael B. Sporn	23
18	Transcriptional Control of Expression of the TGF‐βs 1990 ·Annals of the New York Academy of Sciences ·Anita B. Roberts,(unknown),Paturu Kondaiah,Sonia B. Jakowlew,Fabienne Denhez,Adam B. Glick,Andrew G. Geiser,Shinichi Watanabe,Takafumi Noma,Robert J. Lechleider,Michael B. Sporn	37
19	Oligonucleotide Probes Complementary to Variable Regions of Ribosomal RNA Discriminate between Mycoplasma Species 1987 ·Microbiology ·Ulf B. Göbel,Andrew G. Geiser,(unknown)	87
20	Introduction of a Normal Human Chromosome 11 into a Wilms' Tumor Cell Line Controls Its Tumorigenic Expression 1987 ·Science ·Bernard E. Weissman,Paul J. Saxon,(unknown),Gary R. Jones,Andrew G. Geiser,Eric J. Stanbridge	345

About Andrew G. Geiser

Andrew G. Geiser is a scholar working on Immunology and Allergy, Reproductive Medicine and Toxicology, having authored 47 papers that have together received 5.3k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (18 papers), Estrogen and related hormone effects (8 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Immunology and Allergy (422 citations), Oncology (1.3k citations) and Immunology (1.0k citations). Andrew G. Geiser has collaborated with scholars based in United States, Australia and Russia. Frequent co-authors include Michael B. Sporn, Anita B. Roberts, Alistair B. Roberts, A B Kulkarni, Stefan Karlsson, Kathleen C. Flanders, John J. Letterio, Jerrold M. Ward, Daniel M. Becker and Ashok B. Kulkarni. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact